## Abstract Our previous study showed a characteristic p53 mutational spectrum in lung tumors from lung cancer patients in the Western Pennsylvania region. To further understand the involvement of p53 mutations in lung tumor development, in this study we compared p53 mutational spectra and distribu
Mutational analysis of p51A/TAp63γ, a p53 homolog, in non-small cell lung cancer and breast cancer
✍ Scribed by Sunahara, Masao; Shishikura, Tomotane; Takahashi, Masato; Todo, Satoru; Yamamoto, Naoyoshi; Kimura, Hideki; Kato, Shunsuke; Ishioka, Chikashi; Ikawa, Shuntaro; Ikawa, Yoji
- Book ID
- 110062368
- Publisher
- Nature Publishing Group
- Year
- 1999
- Tongue
- English
- Weight
- 290 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Accumulation of mutant p53 protein occurs frequently in human malignancies, including 40-60% of non-small cell lung carcinomas. The implications of such p53 over-expression, usually assessed by immunohistochemical techniques, for the prognosis of lung cancer patients remain undetermined. In this stu
Validated markers are needed to identify operable lung cancer patients with poor prognosis. About one-half of nonsmall-cell lung cancers (NSCLCs) carry a mutation in the p53 tumor-suppressor gene. We examined 101 NSCLC patients for surgical stage, completeness of resection, tobacco smoking, asbestos
## Abstract __TMS1__ (target of methylation‐induced silencing) is a CpG island‐associated gene that functions in the regulation of apoptosis and encodes a caspase recruitment domain, a recently described motif found in apoptotic signaling molecules. Recent evidence suggests that silencing of genes